OABI

4.6607.36%
CR

Carolyn R. Bertozzi

Founder & Chair of Scientific Advisory Board

Dr. Carolyn R. Bertozzi, Ph.D., M.S., is Co-Founder of TwoStep Therapeutics, Inc. Dr. Bertozzi is Scientific Advisor of Valora Therapeutics, Inc. and Orna Therapeutics, Inc. Dr. Bertozzi serves as Independent Director of Eli Lilly and Company since December 8, 2025. She was Member of Advisory Board of Form Bio, Inc. Dr. Bertozzi is Member of Scientific Advisory Board of Inception Sciences, Inc. Dr. Bertozzi is Board Member & Scientific Advisor of Xaira Therapeutics, Inc. She serves as Advisor at Bevc Management, Llc. She was a Member of Scientific Advisory Board of Orna Therapeutics, Inc. from July 2024. She is Founder & Chair of Scientific Advisory Board of Lycia Therapeutics, Inc. Dr. Bertozzi is Co-Founder & Chair of SAB at Enable Biosciences Inc. She is Advisor at MPM BioImpact LLC. She is the founder of Firefly Bio, Inc. and also serves as its Strategic Advisor since 2026. Dr. Bertozzi served as Chief Scientific Advisor at Acepodia, Inc. since September 2023 until 2025 and serves as Scientific Advisor & serves as its Director since March 7, 2025. She served as Independent Director at Alnylam Pharmaceuticals, Inc. since January 2023 until December 02, 2025 and serves as its Member of Scientific Advisory Board. She serves as Member of Scientific Advisory Board at Rondo Therapeutics since September 2022. Dr. Bertozzi has been an Independent Director of OmniAb, Inc. since November 1, 2022. She serves as Member of Advisory Board at Form Bio Inc. She is Co-Founder and Member of Board of Advisor at InterVenn Biosciences Inc. She serves as Member of Scientific Advisory Board at Colossal Biosciences Inc. and Grace Science, LLC. She serves as Member of Scientific Advisory Board at AmbAgon Therapeutics Inc. She serves as Chairwoman of Scientific Advisory Board at InterVenn Biosciences Inc. She serves as a Co-Founder at Redwood Bioscience, Inc. and also serves as its Chairman of Scientific Advisory Board. Dr. Bertozzi is the Co-Founder of Palleon Pharmaceuticals Inc. Dr. Bertozzi has been an Anne T. and Robert M. Bass Professor of Chemistry Professor of Chemical and Systems Biology and Radiology by courtesy at Stanford University since 2015 and is an Investigator of the Howard Hughes Medical Institute since 2000. She serves as the T.Z. and Irmgard Chu Distinguished Professor of Chemistry and Professor of Molecular and Cell Biology at University of California, Berkeley from 1996 to 2015. She served as a Department Head of Lawrence Berkeley National Laboratory. She is a pioneer for emerging technology and has founded ten biopharmaceutical companies and guided more than a dozen academic and professional organizations and life sciences companies in leadership and board positions. Dr. Bertozzi is also an accomplished entrepreneur and she is well-regarded as the founder of the bioorthogonal chemistry field and has co-founded multiple biopharmaceutical companies including Palleon Pharmaceuticals, InterVenn Bio, Grace Science and Lycia Therapeutics. Dr. Bertozzi serves on the scientific advisory boards of Rayze Bio, Spotlight Therapeutics and Ambigon Therapeutics, among others. She also serves as the Baker Family Director of Stanford University’s Sarafan ChEM-H Institute and as the Anne T. and Robert M. Bass Professor of Chemistry in the Stanford School of Humanities and Sciences. She served as Director of the Molecular Foundry at a nanoscience institute at the Lawrence Berkeley National Laboratory. She has been a Member of Scientific Board at Adheren, Inc. She has been a Member of Scientific & Advisory Board at Catalent, Inc. since August 2015. She serves as a Member of Scientific Advisory Board at Momenta Pharmaceuticals Inc. and Thios Pharmaceuticals Inc. She has been a Member of Scientific Advisory Board of SYMIC Biomedical, Inc. since June 28, 2016. She was a Member of the National Academy of Sciences, the Institute of Medicine, the American Academy of Arts and Sciences and the German Academy of Sciences Leopoldina. Her research interests span the disciplines of chemistry and bacterial with an emphasis on studies of cell surface glycosylation pertinent to disease states. She is a member of, National Academy of the Medicine, National Academy of Inventors, the Royal Society (UK) and Accademia Nazionale dei Lincei. Dr. Bertozzi is a prominent researcher and academician. She has extensive experience at Stanford University and the University of Berkeley, California, two major research institutions. Her deep expertise spans the disciplines of chemistry and biology, with an emphasis on studies of cell surface glycosylation associated with cancer, inflammation and bacterial infection and exploiting this knowledge for development of diagnostic and therapeutic approaches. She had joined as an Independent Director of Eli Lilly and Company since February 10, 2017 until August 23, 2021. She is a Wolf Prize recipient in Chemistry. Dr. Bertozzi is a Member of Board of Broad Institute and Grace Science Foundation. She served as Scientific Advisor at Glympse Bio, Inc. until September 2022. Her Industry Memberships and Other Organizations: American Chemical Society, American Society for Biochemistry and Molecular Biology, American Chemical Society Publications & Editor-in-Chief of ACS Central Science in 2014. Her Honors: MacArthur Genius Award; Lemelson MIT Prize; Heinrich Wieland Prize and National Academy of Sciences Award in the Chemical Sciences. She has been recognized with the Ernst Schering Prize, the MacArthur Foundation Fellowship, the ACS Award in Pure Chemistry, the Presidential Early Career Award in Science and Engineering and the Irving Sigal Young Investigator Award of the Protein Society, among many others. She received UC Berkeley Distinguished Teaching Award and the Donald Sterling Noyce Prize for Excellence in Undergraduate Teaching. Dr. Bertozzi has an Undergraduate Degree in Chemistry from Harvard University, Ph.D. in Chemistry from UC Berkeley and completed her Postdoctoral Work at UC San Francisco (“UCSF”) in the field of Cellular Immunology. She is a Nobel Laureate.

Positions